Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs PFIZER - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE PFIZER CADILA HEALTHCARE/
PFIZER
 
P/E (TTM) x 29.9 47.0 63.6% View Chart
P/BV x 4.8 7.8 62.0% View Chart
Dividend Yield % 0.7 0.4 163.0%  

Financials

 CADILA HEALTHCARE   PFIZER
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-20
PFIZER
Mar-19
CADILA HEALTHCARE/
PFIZER
5-Yr Chart
Click to enlarge
High Rs3523,840 9.2%   
Low Rs2072,080 9.9%   
Sales per share (Unadj.) Rs139.2455.0 30.6%  
Earnings per share (Unadj.) Rs11.893.8 12.5%  
Cash flow per share (Unadj.) Rs18.6109.4 17.0%  
Dividends per share (Unadj.) Rs3.5022.50 15.6%  
Dividend yield (eoy) %1.30.8 164.8%  
Book value per share (Unadj.) Rs101.4658.2 15.4%  
Shares outstanding (eoy) m1,023.7445.75 2,237.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.06.5 30.8%   
Avg P/E ratio x23.731.6 75.2%  
P/CF ratio (eoy) x15.027.1 55.6%  
Price / Book Value ratio x2.84.5 61.3%  
Dividend payout %29.824.0 124.0%   
Avg Mkt Cap Rs m286,033135,420 211.2%   
No. of employees `00013.42.6 509.5%   
Total wages/salary Rs m24,1453,238 745.6%   
Avg. sales/employee Rs Th10,632.77,911.4 134.4%   
Avg. wages/employee Rs Th1,801.21,230.9 146.3%   
Avg. net profit/employee Rs Th898.51,630.7 55.1%   
INCOME DATA
Net Sales Rs m142,53120,815 684.8%  
Other income Rs m1,1391,674 68.0%   
Total revenues Rs m143,67022,489 638.8%   
Gross profit Rs m24,1985,712 423.6%  
Depreciation Rs m6,965714 975.6%   
Interest Rs m3,41873 4,688.6%   
Profit before tax Rs m14,9546,599 226.6%   
Minority Interest Rs m2880-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,1982,309 138.5%   
Profit after tax Rs m12,0444,291 280.7%  
Gross profit margin %17.027.4 61.9%  
Effective tax rate %21.435.0 61.1%   
Net profit margin %8.520.6 41.0%  
BALANCE SHEET DATA
Current assets Rs m87,15427,167 320.8%   
Current liabilities Rs m82,6948,917 927.4%   
Net working cap to sales %3.187.7 3.6%  
Current ratio x1.13.0 34.6%  
Inventory Days Days7168 105.3%  
Debtors Days Days9430 311.6%  
Net fixed assets Rs m133,2368,862 1,503.5%   
Share capital Rs m1,024458 223.8%   
"Free" reserves Rs m102,73329,656 346.4%   
Net worth Rs m103,75730,113 344.6%   
Long term debt Rs m32,14625 128,584.0%   
Total assets Rs m236,86639,400 601.2%  
Interest coverage x5.491.5 5.9%   
Debt to equity ratio x0.30 37,318.9%  
Sales to assets ratio x0.60.5 113.9%   
Return on assets %6.511.1 58.9%  
Return on equity %11.614.2 81.5%  
Return on capital %13.722.1 62.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m52,752428 12,316.6%   
Fx outflow Rs m14,504786 1,844.4%   
Net fx Rs m38,248-358 -10,680.8%   
CASH FLOW
From Operations Rs m25,054978 2,561.5%  
From Investments Rs m-10,123351 -2,882.4%  
From Financial Activity Rs m-10,942-1,099 996.1%  
Net Cashflow Rs m3,989231 1,728.3%  

Share Holding

Indian Promoters % 74.8 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 8.3 7.5 110.7%  
FIIs % 5.9 4.9 120.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 23.7 46.4%  
Shareholders   44,069 85,207 51.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  ALEMBIC  ALKEM LABORATORIES  ELDER PHARMA  

Compare CADILA HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

5 Reasons Why Sensex and Nifty Fell Over 1% Today(Closing)

Indian share markets witnessed heavy selling pressure today, pausing the record rally, with all sectors barring telecom, reeling under pressure.

Related Views on News

PFIZER Announces Quarterly Results (2QFY21); Net Profit Down 14.8% (Quarterly Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

For the quarter ended September 2020, PFIZER has posted a net profit of Rs 1 bn (down 14.8% YoY). Sales on the other hand came in at Rs 6 bn (up 5.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2020 | Updated on Oct 26, 2020

Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

PFIZER Announces Quarterly Results (1QFY21); Net Profit Up 10.3% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, PFIZER has posted a net profit of Rs 1 bn (up 10.3% YoY). Sales on the other hand came in at Rs 5 bn (down 5.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (1QFY21); Net Profit Up 49.3% (Quarterly Result Update)

Aug 21, 2020 | Updated on Aug 21, 2020

For the quarter ended June 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 49.3% YoY). Sales on the other hand came in at Rs 36 bn (up 4.1% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

PFIZER Announces Quarterly Results (3QFY20); Net Profit Up 5.4% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, PFIZER has posted a net profit of Rs 1 bn (up 5.4% YoY). Sales on the other hand came in at Rs 5 bn (up 4.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

My Top Stock Recommendation for 2021 and Beyond(Profit Hunter)

Jan 5, 2021

My new guide will show you the huge potential in future proof businesses.

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Five Wishes and a Will(The Honest Truth)

Jan 4, 2021

Ajit Dayal on the investing strategy for 2021 and beyond.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Jan 15, 2021 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS